Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Organic & Biomolecular Chemistry|October 5, 2019
A facile and regioselective multicomponent synthesis of chiral aryl-1,2-mercaptoamines in water followed by monoamine oxidase (MAO-N) enzymatic resolutionKate Lauder, Domiziana Masci, Anita Toscani, et al.
European Journal of Medicinal Chemistry|April 29, 2022
Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogationDorothy Semenya, Meir Touitou, Domiziana Masci, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 5, 2017
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activitiesSveva Pelliccia, Yu-Hsuan Wu, Antonio Coluccia, et al.
RSC Medicinal Chemistry|July 31, 2025
Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approachDomiziana Masci, Michela Puxeddu, Claudia Colla, et al.
Bioorganic Chemistry|May 21, 2023
Targeting the Grb2 cSH3 domain: Design, synthesis and biological evaluation of the first series of modulatorsMarianna Bufano, Michela Puxeddu, Marianna Nalli, et al.
European Journal of Medicinal Chemistry|June 17, 2019
Switching on the activity of 1,5-diaryl-pyrrole derivatives against drug-resistant ESKAPE bacteria: Structure-activity relationships and mode of action studiesDomiziana Masci, Charlotte Hind, Mohammad K Islam, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
Discovery of κ Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved In Vivo Antinociceptive Effect after Peripheral AdministrationAzzurra Stefanucci, Alice Della Valle, Giuseppe Scioli, et al.
Cancers|March 10, 2022
Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 InhibitorAntonio Coluccia, Marianna Bufano, Giuseppe La Regina, et al.
Journal of Medicinal Chemistry|June 20, 2017
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 AgentsValeria Famiglini, Giuseppe La Regina, Antonio Coluccia, et al.
European Journal of Medicinal Chemistry|September 5, 2020
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strainsMarianna Nalli, Jorge I Armijos Rivera, Domiziana Masci, et al.
Pageof 3